Evidence map›Paper›PMID 42201020›Full record

ArticleMedical sciences (Basel, Switzerland)2026

Regulatory Variation at TERT and TERC Shows Limited Association with Early-Onset Alzheimer's Disease in Carriers of the Mexican Founder Mutation

Celeste Patricia Gazcón-Rivas, Iliannis Yisel Roa-Bruzón, Luis Félix Duany-Almira, Cesar Aly Valdéz-Gaxiola, Sofia Dumois-Petersen, Luis Eduardo Figuera-Villanueva, Antonio Quintero-Ramos, Carmen Magdalena Gurrola-Díaz, Daniel Ortuño-Sahagun, Yeminia Valle and 1 more

Abstract read
In one paragraph

Article in Medical sciences (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Celeste Patricia Gazcón-RivasPrograma de Doctorado en Genética Humana, Departamento de Biología Molecular y Genómica, Centro Universitario de Ciencias de la Salud (CUCS), Universidad de Guadalajara, Guadalajara 44340, Jalisco, Mexico.
Iliannis Yisel Roa-BruzónPrograma de Doctorado en Genética Humana, Departamento de Biología Molecular y Genómica, Centro Universitario de Ciencias de la Salud (CUCS), Universidad de Guadalajara, Guadalajara 44340, Jalisco, Mexico.ORCID 0000-0002-8713-3089
Luis Félix Duany-AlmiraPrograma de Doctorado en Genética Humana, Departamento de Biología Molecular y Genómica, Centro Universitario de Ciencias de la Salud (CUCS), Universidad de Guadalajara, Guadalajara 44340, Jalisco, Mexico.ORCID 0000-0001-9443-7905
Cesar Aly Valdéz-GaxiolaPrograma de Doctorado en Genética Humana, Departamento de Biología Molecular y Genómica, Centro Universitario de Ciencias de la Salud (CUCS), Universidad de Guadalajara, Guadalajara 44340, Jalisco, Mexico.
Sofia Dumois-PetersenCentro Universitario de los Valles, Departamento de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 46708, Jalisco, Mexico.ORCID 0009-0003-5858-8978
Luis Eduardo Figuera-VillanuevaDivisión de Genética, Centro de Investigación Biomédica de Occidente (CIBO), Centro Médico Nacional de Occidente (CMNO), Instituto Mexicano del Seguro Social (IMSS), Guadalajara 44340, Jalisco, Mexico.
Antonio Quintero-RamosInstituto de Investigación en Inmunología, Departamento de Fisiología, Centro Universitario de Ciencias de la Salud (CUCS), Universidad de Guadalajara, Guadalajara 44340, Jalisco, Mexico.ORCID 0000-0001-5963-9712
Carmen Magdalena Gurrola-DíazInstituto de Investigación en Enfermedades Crónico Degenerativas, Centro Universitario de Ciencias de la Salud (CUCS), Departamento de Biología Molecular y Genómica, Universidad de Guadalajara, Guadalajara 44340, Jalisco, Mexico.ORCID 0000-0002-9851-8961
Daniel Ortuño-SahagunInstituto de Neurociencias Traslacionales, Departamento de Neurociencias, Centro Universitario de Ciencias de la Salud (CUCS), Universidad de Guadalajara, Guadalajara 44340, Jalisco, Mexico.ORCID 0000-0002-7443-2514
Yeminia ValleInstituto de Neurociencias Traslacionales, Departamento de Neurociencias, Centro Universitario de Ciencias de la Salud (CUCS), Universidad de Guadalajara, Guadalajara 44340, Jalisco, Mexico.ORCID 0000-0002-4940-022X
Oscar Arias-CarriónDivisión de Neurociencias Clínica, Instituto Nacional de Rehabilitación Luis Guillermo Ibarra Ibarra, Mexico City 14389, Mexico.ORCID 0000-0002-9982-7571

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Alzheimer DiseasePresenilin-1RNATelomeraseAge of OnsetCase-Control StudiesCross-Sectional StudiesFemaleFounder EffectGene FrequencyGenetic Predisposition to DiseaseGenotypeHeterozygoteHumansMaleMexicoPresenilin-1PSEN1 protein, humanRNATelomerasetelomerase RNATERT protein, humanearly-onset Alzheimer’s diseasegenetic modifiersPSEN1telomere biologyTERCTERT

Identifiers

PMID42201020
PMCPMC13214640

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.